The use of reverse phase chromatography methods for the identification and quantification of flutamide and similar structures of substances in biological fluids
Abstract
The object of the study was antitumor drug flutamide (2-methyl-N- (4-nitro-3- (trifluoromethyl)
phenyl) propanamide) having significant toxicity and a number of structurally related compounds. As discussed
TLC analytical methods, liquid chromatography, low pressure column and HPLC.
The features of the chromatographic activity flutamide, 4-nitro-3-trifluoromethylaniline, 2-methyl-
N- (4-amino-3- (trifluoromethyl) phenyl) propanamide, and 2-methyl-N- (4-amino-3- (trifluoromethyl )
phenyl) propanamide in thin layers and columns obraschёnnofazovyh sorbents using mobile phases based on
water and buffer solutions with addition of 20-80% (by volume) of organic modifiers. The parameters of this
group of substances Chromatographic methods of TLC, column chromatography, HPLC and low pressure.
Best mobile phases for thin layer chromatography in silica gel CTX-1A, modified with C14 to C15 alkanes,
were water-acetonitrile (60:40) and 20 mM KH2PO4 buffer solution (pH 3.5) - acetonitrile (65:35) in the
sorbent column «Silasorb C-18»- water - acetonitrile (40:60), column sorbent LiChrospher RP - 20 mM
KH2PO4 solution (pH 5.3) - acetonitrile (65:35). A technique to identify and quantify flutamide, and its precursor the synthesis of two metabolites in biological fluids by applying reverse phase chromatography methods.
Downloads
References
M, Novaja volna Publ., 2012, 1216 p.
2. Lazaros G., Angelopoulou P., Chryssou S.,
Bourlis A., Anagnostopoulos G., Tassopoulos
N.C., Annals of gastroenterology, 2001, Vol.
14, No 2, pp. 125-127.
3. Hung H.C., Lin I.H., Shiue K.F., Huang
B.C., Journal Intern. Med. Taiwan 2007, Vol.
18, pp. 35-39.
4. Bakdash A., Ganswindt M., Herre S. еt аl.,
Toxichem+Krimtech, 2006, Vol. 73, No 2, pp.
61-65.
5. Shormanov V.K., Andreeva Ju.V.,
Omel'chenko V.A., Sudebno-medicinskaja
jekspertiza, 2014,T. 57, No 5, рр. 18-20.
6. Umrethia M.L., Ghosh P.K., Majithiya
R.J., Murthy R.S.R., Ars Pharm, 2005, Vol. 46,
No 2, рр. 109-124.
7. Farthing D., Sica D., Fakhry I. et al., Biomedical
Chromatography, 1994, Vol. 8, No 5,
pp. 251–254.
8. Jalalizadeh H., Souri E., Ghanami H.R.J. еt
аl., International Journal of Pharmacology,
2006, Vol. 2, рр. 221-225.
9. Styskin E.L., Icykson L.B., Braude E.V.
Prakticheskaja vysokojeffektivnaja zhidkostnaja
hromatografija. M., Himija, 1986, 288 р.
10.Rudakov O.B. Rastvoritel' kak sredstvo
upravlenija processom v zhidkostnoj hromatografii.
Voronezh, RIC EF VGU, 2003, 300 р.
11.Pospelova A.A., Karpova L.N., Malkova
T.L., Toksikologicheskij vestnik, 2012, No 2,
рр. 20-23.
12.Sumina E.G., Shtykov S.N., Uglanova
V.Z., Kulakova N.V. Tonkoslojnaja hromatografija.
Teoreticheskie osnovy i prakticheskoe
primenenie. Saratov, Izdatel'stvo Saratovskogo
gosudarstvennogo universiteta, 2012, 128 р.
13.Shunmakers P. Optimizacija selektivnosti v
hromatografii. M., Mir, 1989, 399 р.
14.Guidance for Industry: Bioanalytical method
validation. U.S. Department of Health and
Human Services, Food and Drug Administration,
Center for Drug Evolution and Research
(CDER). U.S. Government Printing Office.
Washington, DC, 2001, 22 р.
15.Guideline on validation of bioanalytical
methods (draft). European Medicines Agency.
Committee for medicinal products for human
use. London, 2009, 23 р.
